Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/25/2025

Hydroxychloroquine Treatment for SLE in Women of Childbearing Age

Introduction to Hydroxychloroquine Therapy

  • The American College of Rheumatology recommends hydroxychloroquine at 200-400 mg daily for adult women of childbearing age with SLE, as it reduces disease flares, organ damage, thrombotic events, and mortality while being safe for the fetus 1, 2, 3

Dosing Strategy

  • The FDA-approved dosage for SLE is 200 mg once daily or 400 mg once daily or in two divided doses, never exceeding 5 mg/kg actual body weight per day to minimize retinal toxicity risk 1, 2, 3
  • For patients with eGFR <30 ml/min/1.73 m², reduce the dose by 25% 1, 2

Critical Benefits for This Population

  • Hydroxychloroquine reduces disease flares by 2.5-fold compared to discontinuation, decreases organ damage accrual and improves survival, and allows glucocorticoid dose reduction, minimizing steroid-related complications 2, 3
  • Hydroxychloroquine is safe and recommended during pregnancy and breastfeeding, decreasing lupus activity during pregnancy without fetal harm 4, 5, 2

Pre-Treatment Screening

  • Measure glucose-6-phosphate dehydrogenase (G6PD) levels in men, especially those of African, Asian, or Middle Eastern origin, though hemolysis risk appears low 1, 2
  • Baseline ophthalmologic examination is NOT required according to updated Royal College of Ophthalmologists guidelines 1

Monitoring Requirements

  • Begin annual eye examinations after 5 years of therapy in standard-risk patients, and after 1 year if additional risk factors are present 1, 2, 3
  • Retinal toxicity affects 0.5% after 6 years, 7.5% in long-term users generally, and can exceed 20% after 20 years of treatment 1, 2, 3

Duration of Therapy

  • The American College of Rheumatology recommends indefinite continuation of hydroxychloroquine due to beneficial effects, as discontinuation increases flare risk 2.5-fold 2

Common Pitfalls to Avoid

  • Do not exceed 5 mg/kg actual body weight—this is the single most important factor in preventing retinal toxicity 1, 2, 3
  • Do not discontinue hydroxychloroquine during pregnancy—it is safe and beneficial 4, 5, 2, 3

Alternative Considerations

  • Chloroquine may substitute for hydroxychloroquine due to lower cost and similar mechanism of action, but has increased toxicity risk and requires more careful monitoring 1, 2